De Groot at al. showed that, in patients recently diagnosed with T1D, fecal microbiota transplantation in the 12 months after disease onset can halt the decline in endogenous insulin production, probably by the preservation of residual β-cell function [200]. The gene discussed is INS; the disease is type 1 diabetes mellitus.